Response rate noted by Foster GR et al, in 409 patients with decompensated cirrhosis due to genotype 3, was 68.8% with sofosbuvir/Ribavirin therapy.12 Low serum albumin, high CTP score and presence of cirrhosis were associated with less chances of SVR12 in our patients as shown in Table-II. The gene discussed is ALB; the disease is Cirrhosis.